No Data
No Data
Huaren Pharmaceutical (SZSE:300110) Has A Pretty Healthy Balance Sheet
Huaren Pharmaceutical (300110.SZ): The monkeypox virus nucleic acid detection kit has obtained the CE certification of the European Union.
Huaren Pharmaceutical (300110.SZ) stated on the investor interaction platform on August 13th that the company's monkeypox virus nucleic acid detection kit has obtained EU CE certification. At present, no domestic registration certificate has been obtained, and the company will continue to follow relevant matters.
Huaren Pharmaceutical's Unit Gets Nod to Register Pentoxifylline
Huaren Pharmaceutical (300110.SZ): Its subsidiary Anhui Hengxing Pharmaceutical has obtained a drug registration certificate for its Ketamine Hydrochloride Injection.
On August 5, Gelunhui reported that Huaren Pharmaceutical (300110.SZ) announced that its wholly-owned subsidiary Anhui Hengxing Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui Hengxing Pharmaceutical") has received the "Drug Registration Certificate" for Ketococonazole Injection approved and issued by the National Medical Products Administration. Ketococonazole Injection is suitable for peripheral arterial disease (intermittent claudication or rest pain) and inner ear circulation disorder, and is a category B medical insurance product in China.
Huaren Pharmaceutical (300110.SZ): Its subsidiary has obtained a medical instruments registration certificate for disposable nasal oxygen tubes.
On July 18th, Gelonhui reported that Huaren Pharmaceutical (300110.SZ) announced that its wholly-owned subsidiary, Qingdao Huaren Medical Supplies Co., Ltd., recently received a registration certificate for medical instruments for the disposable nasal oxygen tube approved and issued by the Shandong Provincial Drug Administration.
Is It Smart To Buy Huaren Pharmaceutical Co., Ltd. (SZSE:300110) Before It Goes Ex-Dividend?
No Data